First entry: Thursday, April 8, 2021, 13:07
Australia is not currently going to modify deliveries of the AstraZeneca vaccine against COVID-19, Prime Minister Scott Morrison said today after the European Medicines Agency (EMA) identified a possible link between rare blood clots and blood clots. vaccine.
EMA announced yesterday that it has identified rare cases of blood clots in adults who have been vaccinated despite the fact that, as it announced, the benefits of the vaccine outweigh the risks.
Australian health authorities have ordered an urgent inquiry into the findings by Coreper, with Morrison awaiting updates later today from the Drug Administration and the Vaccination Advisory Group.
Australian Health Minister Greg Hunt said the country’s drug regulator was free to make its decision “honestly and without fear”, including the possibility of ending the vaccine for people under the age of 30.
“If they give us age restrictions or other changes, we will do it, we will adopt it,” Hunt said in a televised news briefing.
Australian authorities had pledged to make at least 4 million first installments by the end of March but had only 670,000 installments available. The government attributed the delay to issues raised with Europe.
The Australian Government is considering accelerating the AstraZeneca Vaccine Vaccination Schedule as local production of 50 million doses in Australia is planned by CSL Ltd.
Vaccinations in the country, started much later, compared to other countries, due to the small number of cases of infection by COVID-19, with less than 29,400 cases of infection and 909 deaths since the beginning of the pandemic.
Last Updated: Thursday, 8 April 2021, 13:07